Blacksburg, VA, United States of America

Richard Gandour

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Landos Biopharma, Inc., Virginia Tech Intellectual Properties Inc., Biotherapeutics, Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Gandour. Retrieved from https://idiyas.com/inventor/richard-gandour

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 82(Granted Patents)

Company Filing History:

7 out of 18

Landos Biopharma, Inc.

patents

3 out of 824

Virginia Tech Intellectual Properties Inc.

patents

1 out of 3

Biotherapeutics, Inc.

patents

4. 1 out of 5

Nimmune Biopharma, Inc.

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502388 - Lanthionine synthetase C-like 2-based therapeutics (2025-12-23),

2. 12359008 - Alternating copolymers of selected unsymmetrically substituted stilbenes and maleic anhydride or N-substituted maleimides (2025-07-15),

3. 11571419 - Lanthionine synthetase C-like 2-based therapeutics (2023-02-07),

4. 10849895 - Lanthionine synthetase C-like 2-based therapeutics (2020-12-01),

5. 10682349 - Lanthionine synthetase C-like 2-based therapeutics (2020-06-16),

6. 10493072 - Lanthionine synthetase C-like 2-based therapeutics (2019-12-03),

7. 10201538 - Lanthionine synthetase C-like 2-based therapeutics (2019-02-12),

8. 10028950 - Lanthionine synthetase C-like 2-based therapeutics (2018-07-24),

9. 9839635 - Lanthionine synthetase C-like 2-based therapeutics (2017-12-12),

10. 9556146 - Lanthionine synthetase C-like 2-based therapeutics (2017-01-31),

11. 7524535 - Method of protecting metals from corrosion using thiol compounds (2009-04-28),

12. 6656936 - Carnitine analogues as topical, microbicidal spermicides (2003-12-02),

Title: The Innovative Contributions of Richard Gandour

Introduction

Richard Gandour, a notable inventor based in Blacksburg, VA, has made significant strides in the field of therapeutics with a total of 10 patents to his name. His work primarily focuses on innovative treatments that target critical pathways in various diseases.

Latest Patents

Among his latest contributions, Gandour has developed therapeutics based on the lanthionine synthetase C-like protein 2 pathway. These compounds have shown promising potential in treating a range of conditions, including infectious diseases, autoimmune disorders, diabetes, and chronic inflammatory diseases. This work underscores his commitment to advancing medical science through innovative solutions.

Career Highlights

Gandour's career includes significant roles at prominent organizations such as Landos Biopharma, Inc. and Virginia Tech Intellectual Properties, Inc. These companies have provided him with a platform to further his research and develop his patented innovations aimed at improving patient outcomes through targeted therapies.

Collaborations

Throughout his career, Richard Gandour has collaborated with esteemed colleagues, including Josep Bassaganya-Riera and Adria Carbo Barrios. These partnerships have facilitated a dynamic exchange of ideas and expertise, enhancing the impact of his inventions in the biomedical field.

Conclusion

In conclusion, Richard Gandour's innovative approach and dedication to developing therapeutic solutions highlight his valuable contributions to the field of medicine. His work continues to inspire future generations of inventors and medical researchers striving for breakthroughs that address pressing health challenges.

Profile summary based on public USPTO records.